Dyspepsia, characterized by upper abdominal discomfort, early satiety, or postprandial fullness, may affect a similar proportion of patients and can contribute to reduced caloric intake and weight loss, though it may also impact quality of life if severe or persistent
This accessibility opens a promising avenue for preventive and therapeutic strategies targeting the central nervous system (CNS)
However, results can vary from person to person, and it is crucial to consult with a healthcare professional before beginning any new supplement regimen
Book a consultation to learn how we can help you achieve your goals
Patients who report feeling less bloated on GHK-Cu are likely experiencing a secondary effect of its systemic inflammation reduction rather than any specific metabolic action
compounding pharmacy subcutaneous versions are a different route with different pharmacokinetics